Yoshimura T, Leonard E J
Immunopathology Section, National Cancer Institute-Frederick Cancer Research Facility, MD 21701.
J Immunol. 1990 Jul 1;145(1):292-7.
The binding of human monocyte chemoattractant protein-1 (MCP-1) to human monocytes was studied. MCP-1 was radioiodinated with Iodo-beads (Pierce Chemical Co., Rockford, IL) without significant loss of biologic activity. 125I-MCP-1 binding to PBMC occurred within 5 min at 0 degrees C and the binding was inhibited by unlabeled MCP-1 dose dependently but not by neutrophil attractant/activation protein-1 or FMLP. 125I-MCP-1 bound to monocytes; no significant binding to either neutrophils or lymphocytes was observed. Scatchard plot analysis indicated that monocytes had a minimum of 1700 +/- 600 binding sites per cell with a Kd of 1.9 +/- 0.2 x 10(-9) M. For analysis of binding by flow cytometry, MCP-1 was biotinylated. In contrast to radioiodination, biotinylation resulted in loss of activity; potency was 10-fold less, but the efficacy was retained. Detection by flow cytometry of bound biotinylated MCP-1 with avidin-FITC confirmed results obtained with 125I-MCP-1. Biotinylated MCP-1 bound to monocytes but not to lymphocytes; and the binding was inhibited by a 100-fold excess of unlabeled MCP-1.
研究了人单核细胞趋化蛋白-1(MCP-1)与人单核细胞的结合。使用碘珠(Pierce化学公司,伊利诺伊州罗克福德)对MCP-1进行放射性碘化标记,其生物学活性无明显损失。在0℃下,125I-MCP-1与外周血单核细胞(PBMC)的结合在5分钟内即可发生,且未标记的MCP-1可剂量依赖性地抑制该结合,但中性粒细胞趋化因子/激活蛋白-1或N-甲酰甲硫氨酸-亮氨酸-苯丙氨酸(FMLP)则无此作用。125I-MCP-1与单核细胞结合;未观察到其与中性粒细胞或淋巴细胞有明显结合。Scatchard作图分析表明,单核细胞每个细胞至少有1700±600个结合位点,解离常数(Kd)为1.9±0.2×10-9M。为了通过流式细胞术分析结合情况,对MCP-1进行了生物素化标记。与放射性碘化标记不同,生物素化标记导致活性丧失;效价降低了10倍,但仍保留了效力。用抗生物素蛋白-异硫氰酸荧光素(avidin-FITC)通过流式细胞术检测结合的生物素化MCP-1,证实了用125I-MCP-1所获得的结果。生物素化的MCP-1与单核细胞结合,但不与淋巴细胞结合;并且100倍过量的未标记MCP-1可抑制该结合。